Navigation Links
New Vaccine May Offer Protection From Deadly Nipah Virus
Date:8/8/2012

WEDNESDAY, Aug. 8 (HealthDay News) -- A new vaccine developed by a team of researchers may protect people and livestock from the deadly Nipah virus.

The virus, upon which the Hollywood blockbuster Contagion was modeled, is found naturally in several species of fruit bats. Once infected, it causes serious respiratory distress syndrome and encephalitis. The researchers noted that in more than 75 percent of cases, those infected with Nipah die.

The researchers, led by Dr. Heinz Feldmann, chief of the Rocky Mountain Laboratories' Laboratory of Virology, conducted their research on live Nipah virus in a high-security facility in Hamilton, Mont.

They found that immunizing African green monkeys with a vaccine based on the Hendra virus attachment G glycoprotein completely protected them against Nipah virus infection.

"There are currently no approved vaccines for prevention of infection and disease caused by Nipah and Hendra for use by people or livestock," corresponding author Christopher Broder, a professor of microbiology at the Uniformed Services University in Bethesda, Md., said in a university news release. "This Hendra-sG vaccine has now been shown to be fully effective against infection by both Nipah and Hendra virus in at least three animal species, demonstrating its potential as a safe and effective vaccine, as a possible livestock vaccine and now also as possible vaccine for use in people."

The U.S. National Institutes of Health and U.S. Centers for Disease Control and Prevention both classify the Nipah virus and the Hendra virus as biothreat agents.

The Hendra-sG vaccine is produced in the laboratory using molecular techniques, the study authors noted.

"Since the vaccine is only a recombinant piece of the virus, it can be produced by itself and purified. [It] is a type of vaccine known as a subunit, thus making it extremely safe to use," study lead author Katharine Bossart, assistant professor in the department of microbiology at Boston University School of Medicine, said in a news release. Bossart developed the vaccine while at Uniformed Services University.

"This work now provides key evidence that a simple and safe recombinant vaccine against Nipah virus is possible," study co-author Thomas Geisbert, professor in the department of microbiology and immunology at the University of Texas Medical Branch and the Galveston National Laboratory, said in the news release. "Demonstrating this in a nonhuman primate model is a major step forward in developing it for future therapeutic use in people."

The findings were published online Aug. 8 in the journal Science Translational Medicine. Although the vaccine was successful in animal studies, results may be different in humans.

More information

The World Health Organization provides more information on Nipah virus.

-- Mary Elizabeth Dallas

SOURCE: Uniformed Services University of the Health Sciences, news release, Aug. 8, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. CDC Preparing Vaccine for New Swine Flu
2. Poor Sleep Hampers Vaccine Effectiveness: Study
3. Is Improved Vaccine Causing Whooping Cough Outbreaks?
4. Sleep affects potency of vaccines
5. NIDA supports development of combined anti-heroin and HIV vaccine
6. Scientists explore new class of synthetic vaccines
7. Mount Sinai researchers discover new target for vaccine development in abundant immune cells
8. Researchers study vaccine as potential weapon against aggressive brain tumors
9. Duke receives new grant for AIDS vaccine research
10. Parental consent for HPV vaccine should not be waived, poll says
11. Antibodies for new rotavirus vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vaccine May Offer Protection From Deadly Nipah Virus
(Date:4/21/2017)... Utah (PRWEB) , ... April 21, 2017 , ... ... wilderness therapy treatment for adolescents and young adults, has kicked off its 4th ... April 23rd. This year’s theme is “Attachment Informed Therapy for Mental Health ...
(Date:4/21/2017)... ... 21, 2017 , ... The Patient Advocacy Community of The Beryl Institute presented ... Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions to the ... award at The Beryl Institute’s annual Patient Experience Conference on March 20 ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... ... Providing for loved ones before one’s passing is of paramount importance. However, ... “Now more than ever there are some questions that are far too critical to ... attorney Lisa Edgar Dickman, founder of the Law Offices of Lisa Edgar Dickman. ...
(Date:4/21/2017)... ... ... During April 21-23, Super-Sod will join the vendor market of the Sacred ... — from the avid gardener to the landscape admirer — during the three-day schedule. ... a grand venue, and we are certainly looking forward to participating in this year’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: